Global Plasma Fractionation Market is expected to reach USD 41.95 Billion by 2026 from USD XXBillion in 2019 at CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology :- Request Free Sample Report Plasma Fractionation is basically processing where various components of plasma are separated through blood fractionation and then Fresh Frozen Plasma (FFP) can be used for replacement of clotting factors. Plasma Fractionation is useful in the prevention and treatment of life-threatening diseases caused by trauma, immunologic disorders, and infections. Global Plasma Fractionation Market is segmented by product, application, end user, and geography. Product segment is sub-segmented as immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and other plasma products. Application segment is divided as neurology, immunology, hematology, critical care, and others. An end-user segment is classified as hospitals & clinics, clinical research laboratories, and academic institutes. Hospital and clinic end-user segment is expected to lead the market growth during the forecast period. This growth is attributed to increasing number of hospitals & clinics across the globe and increasing adoption of plasma products in the treatment of various diseases. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increasing geriatric population across the globe and rising prevalence of respiratory diseases are trending the overall Global Plasma Fractionation Market. However, high cost and limited reimbursement will restrain market growth. North America is expected to dominate the Plasma Fractionation Market in forecast period followed by Europe and APAC. Technologically advanced research and increased use of immunoglobulins in neurological diseases and prophylaxis treatments for diagnosed patients in this region will fuel the Plasma Fractionation Market in the North America region.
Global Plasma Fractionation Market Key Highlights:• Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Plasma Fractionation Market analysis and comprehensive segmentation with respect to the product, application, end user, and geography to assist in strategic business planning • Global Plasma Fractionation Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions
Global Plasma Fractionation Market Research Methodology:The research methodology used in this report contains various secondary sources including Bloomberg, Hoovers, and Factiva. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of this market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Plasma Fractionation Market globally.
Key Players in the Global Plasma Fractionation Market Are:• Green Cross Corporation • Baxalta Incorporated • Shanghai Raas Blood Products • Japan Blood Products Organization • Bio Products Laboratory (BPL) • China Biologic Products • Sanquin • Biotest • LFB • Kedrion • Octapharma • Shire • Grifols • CSL • Emergent BioSolutions • Intas Biopharmaceuticals • Bharat Serums and Vaccines Limited • SK Plasma • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. • KabaFusion • Centurion Pharma
Global Plasma Fractionation Market Key Target Audience:• Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Healthcare Institutions (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Pharmacies, Ambulatory Centers, and Outpatient Clinics) • Health insurance provider companies • Research and development (R&D) companies • Pharmaceutical and biotechnological companies • Plasma fractionation products manufacturers and distributors • Healthcare service providers (including hospitals and clinics) • Contract research organizations (CROs) • Government Bodies
The scope of the Global Plasma Fractionation Market: Inquire before buyingResearch report categorizes the Global Plasma Fractionation Market based on product, application, end user, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Plasma Fractionation Market with key developments in companies and market trends.
Global Plasma Fractionation Market, By Product:• Immunoglobulin • Intravenous Immunoglobulin (IVIG) • Subcutaneous Immunoglobulin (SCIG) • Other Immunoglobulins • Coagulation Factor Concentrates • Factor VIII • Factor IX • Von Willebrand Factor • Prothrombin Complex Concentrate • Fibrinogen Concentrates • Factor XIII • Albumin • Protease Inhibitors • Other Plasma Products
Global Plasma Fractionation Market, By Application:• Neurology • Immunology • Hematology • Critical Care • Pulmonology • Hemato-Oncology • Rheumatology • Other Applications
Global Plasma Fractionation Market, By End-User:• Hospitals & Clinics • Clinical Research Laboratories • Academic Institutes
Global Plasma Fractionation Market, By Geography:• North America • Europe • Asia Pacific • Middle East & Africa • Latin America
Available Customization:Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT (2019-2026) 5.1. Introduction 5.2. Immunoglobulin 5.2.1. Immunoglobulin Market Overview 5.2.2. Immunoglobulin Market Size & Forecast 220.127.116.11. Intravenous Immunoglobulin (IVIG) 18.104.22.168. Subcutaneous Immunoglobulin (SCIG) 22.214.171.124. Other Immunoglobulins 5.3. Coagulation Factor Concentrates 5.3.1. Coagulation Factor Concentrates Market Overview 5.3.2. Coagulation Factor Concentrates Market Size & Forecast 126.96.36.199. Factor VIII 188.8.131.52. Factor IX 184.108.40.206. Von Willebrand Factor 220.127.116.11. Prothrombin Complex Concentrate 18.104.22.168. Fibrinogen Concentrates 22.214.171.124. Factor XIII 5.4. Albumin 5.4.1. Albumin Market Overview 5.4.2. Albumin Market Size & Forecast 5.5. Protease Inhibitors 5.5.1. Protease Inhibitors Market Overview 5.5.2. Protease Inhibitors Market Size & Forecast 5.6. Other Plasma Products 5.6.1. Other Plasma Products Market Overview 5.6.2. Other Plasma Products Market Size & Forecast 6. GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION (2019-2026) 6.1. Introduction 6.2. Neurology 6.2.1. Neurology Market Overview 6.2.2. Neurology Market Size & Forecast 6.3. Immunology 6.3.1. Immunology Market Overview 6.3.2. Immunology Market Size & Forecast 6.4. Hematology 6.4.1. Hematology Market Overview 6.4.2. Hematology Market Size & Forecast 6.5. Critical Care 6.5.1. Critical Care Market Overview 6.5.2. Critical Care Market Size & Forecast 6.6. Pulmonology 6.6.1. Pulmonology Market Overview 6.6.2. Pulmonology Market Size & Forecast 6.7. Hemato-Oncology 6.7.1. Hemato-Oncology Market Overview 6.7.2. Hemato-Oncology Market Size & Forecast 6.8. Rheumatology 6.8.1. Rheumatology Market Overview 6.8.2. Rheumatology Market Size & Forecast 6.9. Other Applications 6.9.1. Other Applications Market Overview 6.9.2. Other Applications Market Size & Forecast 7. GLOBAL PLASMA FRACTIONATION MARKET, BY END-USER (2019-2026) 7.1. Introduction 7.2. Hospitals & Clinics 7.2.1. Hospitals & Clinics Market Overview 7.2.2. Hospitals & Clinics Market Size & Forecast 7.3. Clinical Research Laboratories 7.3.1. Clinical Research Laboratories Market Overview 7.3.2. Clinical Research Laboratories Market Size & Forecast 7.4. Academic Institutes 7.4.1. Academic Institutes Market Overview 7.4.2. Academic Institutes Market Size & Forecast 8. GLOBAL PLASMA FRACTIONATION MARKET, BY GEOGRAPHY (2019-2026) 8.1. North America Plasma Fractionation Market 8.1.1. North America Plasma Fractionation Market, By Product 8.1.2. North America Plasma Fractionation Market, By Application 8.1.3. North America Plasma Fractionation Market, By End-User 8.1.4. North America Plasma Fractionation Market, by Region 126.96.36.199. U.S. Plasma Fractionation Market 188.8.131.52. Canada Plasma Fractionation Market 184.108.40.206. Mexico Plasma Fractionation Market 8.2. Europe Plasma Fractionation Market 8.2.1. Europe Plasma Fractionation Market, By Product 8.2.2. Europe Plasma Fractionation Market, By Application 8.2.3. Europe Plasma Fractionation Market, By End-User 8.2.4. Europe Global Plasma Fractionation Market, by Region 220.127.116.11. France Plasma Fractionation Market 18.104.22.168. Germany Plasma Fractionation Market 22.214.171.124. U.K. Plasma Fractionation Market 126.96.36.199. Italy Plasma Fractionation Market 188.8.131.52. Spain Plasma Fractionation Market 184.108.40.206. Rest of Europe Plasma Fractionation Market 8.3. Asia Pacific Plasma Fractionation Market 8.3.1. Asia-Pacific Plasma Fractionation Market, By Product 8.3.2. Asia-Pacific Plasma Fractionation Market, By Application 8.3.3. Asia-Pacific Plasma Fractionation Market, By End-User 8.3.4. Asia-Pacific Plasma Fractionation Market, by Region 220.127.116.11. China Plasma Fractionation Market 18.104.22.168. Japan Plasma Fractionation Market 22.214.171.124. India Plasma Fractionation Market 126.96.36.199. South Korea Plasma Fractionation Market 188.8.131.52. Rest of Asia Pacific Plasma Fractionation Market 8.4. Middle East & Africa Plasma Fractionation Market 8.4.1. Middle East & Africa Plasma Fractionation Market, By Product 8.4.2. Middle East & Africa Plasma Fractionation Market, By Application 8.4.3. Middle East & Africa Plasma Fractionation Market, By End-User 8.4.4. Middle East & Africa Plasma Fractionation Market, by Region 184.108.40.206. South Africa Plasma Fractionation Market 220.127.116.11. Rest of Middle East and Africa Plasma Fractionation Market 8.5. Latin America Plasma Fractionation Market 8.5.1. Latin America Plasma Fractionation Market, By Product 8.5.2. Latin America Plasma Fractionation Market, By Application 8.5.3. Latin America Plasma Fractionation Market, By End-User 8.5.4. Latin America Plasma Fractionation Market, by Region 18.104.22.168. Brazil Plasma Fractionation Market 22.214.171.124. Rest of Latin America Plasma Fractionation Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Green Cross Corporation 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Developments 9.3.2 Baxalta Incorporated 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Developments 9.3.3 Shanghai Raas Blood Products 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Developments 9.3.4 Japan Blood Products Organization 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Developments 9.3.5 Bio Products Laboratory (BPL) 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Developments 9.3.6 China Biologic Products 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Developments 9.3.7 Sanquin 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.8 Biotest 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.9 LFB 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.10 Kedrion 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.11 Octapharma 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.12 Shire 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.13 Grifols 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.14 CSL 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.15 Emergent BioSolutions 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.16 Intas Biopharmaceuticals 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.17 Bharat Serums and Vaccines Limited 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.18 SK Plasma 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development 9.3.19 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. 126.96.36.199 Overview 188.8.131.52 Products/ End-User 184.108.40.206 Strategy 220.127.116.11 Key Development 9.3.20 KabaFusion 18.104.22.168 Overview 22.214.171.124 Products/ End-User 126.96.36.199 Strategy 188.8.131.52 Key Development 9.3.21 Centurion Pharma 184.108.40.206 Overview 220.127.116.11 Products/ End-User 18.104.22.168 Strategy 22.214.171.124 Key Development